Linezolid vs Vancomycin/Cefazolin in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections

Trial Profile

Linezolid vs Vancomycin/Cefazolin in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections

Discontinued
Phase of Trial: Phase III

Latest Information Update: 17 Feb 2017

At a glance

  • Drugs Linezolid (Primary) ; Cefazolin; Gentamicin; Vancomycin
  • Indications Bacteraemia; Catheter infections; Gram-positive infections
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 28 Sep 2008 Planned end date (Sep 2006) added as reported by CT.gov
    • 27 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top